Skip to main navigation Skip to search Skip to main content

Injection of alpha-MSH, but not beta-endorphin, into the PVN decreases POMC gene expression in the ARC

  • Eun-Mee Kim
  • , MK Grace
  • , E O'Hare
  • , CJ Billington
  • , AS Levine

Research output: Contribution to journalArticlepeer-review

Abstract

beta-Endorphin (beta-END) and alpha-melanocyte stimulating hormone (alpha-MSH), neuropeptides derived from proopiomelanocortin (POMC), have opposite effects on eating behavior. We injected rats with alpha-MSH (0.6 nmol) or beta-END (1 nmol) into the PVN (three times in a 26 h period). These doses of alpha-MSH and beta-END decreased and increased feeding respectively. Following alpha-MSH administration into the PVN, m RNA levels of POMC decreased by 17%, whereas there was no significant change in gene expression of either proDynorphin or proEnkephalin. PVN injection of beta-END failed to alter gene expression of POMC, proDynorphin or proEnkephalin. These data suggest that a feedback pathway exists between the PVN and ARC for alpha-MSH and POMC, but not for beta-END and POMC.
Original languageEnglish
Pages (from-to)497-500
JournalNeuroReport
Volume13
Issue number4
Publication statusPublished (in print/issue) - Mar 2002

Fingerprint

Dive into the research topics of 'Injection of alpha-MSH, but not beta-endorphin, into the PVN decreases POMC gene expression in the ARC'. Together they form a unique fingerprint.

Cite this